18.70
1.25%
0.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.47
Offen:
$18.46
24-Stunden-Volumen:
9.48M
Relative Volume:
3.08
Marktkapitalisierung:
$3.72B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-18.51
EPS:
-1.01
Netto-Cashflow:
$365.00M
1W Leistung:
-5.17%
1M Leistung:
+0.97%
6M Leistung:
-26.52%
1J Leistung:
-45.03%
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
18.70 | 3.72B | 3.90B | -413.00M | 365.00M | -2.07 |
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-04 | Eingeleitet | Mizuho | Neutral |
2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-10-25 | Bestätigt | Needham | Buy |
2024-08-20 | Bestätigt | Needham | Buy |
2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
2023-11-16 | Eingeleitet | Needham | Buy |
2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
2022-06-02 | Hochstufung | UBS | Neutral → Buy |
2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
2021-08-06 | Bestätigt | Barrington Research | Outperform |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
2020-12-18 | Herabstufung | Stifel | Buy → Hold |
2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
2020-02-19 | Bestätigt | Stifel | Buy |
2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
2019-07-26 | Eingeleitet | Evercore ISI | In-line |
2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)? - Simply Wall St
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY - GlobeNewswire Inc.
Deadline to Lead in Securities Fraud Lawsuit against DENTSPLY SIRONA Inc. (XRAY) is January 27, 2025Contact Kaplan Fox & Kilsheimer LLP | FinancialContent Business Page - Financial Content
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against DENTSPLY SIRONA Inc. (XRAY)Deadline is January 27, 2025 | FinancialContent Business Page - Financial Content
XRAY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Class Action Filed Against Dentsply Sirona Inc. (XRAY) Seeking Recovery for InvestorsContact Levi & Korsinsky - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY - The Bakersfield Californian
Root Canal Irrigators Market Overall Study Report 2024-2031 | - openPR
Lost Money on Dentsply Sirona Inc.(XRAY)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - AccessWire
Levi & Korsinsky Notifies Shareholders of Dentsply Sirona Inc. (XRAY) of a Class Action Lawsuit and an Upcoming Deadline - AccessWire
Dental Maker Sued After Teeth Aligner News Spurs Stock Plummet - Bloomberg Law
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire
Dentsply Sirona Hit With Class Action Lawsuit Over $495M Byte Aligner Scandal - StockTitan
The Gross Law Firm Notifies Shareholders of Dentsply Sirona Inc.(XRAY) of a Class Action Lawsuit and an Upcoming Deadline - Marketscreener.com
The Gross Law Firm Notifies Shareholders of Dentsply Sirona Inc. - GuruFocus.com
Geode Capital Management LLC Decreases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
Dental Prosthetics Market Future Business Opportunities - openPR
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Dentsply Sirona, Inc. (NASDAQ: XRAY) - Business Wire
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
XRAY INVESTOR ALERT: Kirby McInerney LLP Notifies Dentsply - GlobeNewswire
Investors who lost money on Dentsply Sirona Inc.(XRAY) should contact The Gross Law Firm about pending Class ActionXRAY - The Eastern Progress Online
Dentsply Sirona Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationXRAY - AccessWire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA - The Malaysian Reserve
DENTSPLY SIRONA INC. (NASDAQ: XRAY) DEADLINE ALERT: - GlobeNewswire
Transforming digital dentistry: Exploring Primescan 2 and the future of connected technology - Dental Tribune International
Barclays PLC Buys 54,920 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
XRAY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Dentsply Sirona Inc. to Contact the Firm Today! - AccessWire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel - The Bakersfield Californian
Robbins LLP Reminds XRAY Investors of the Pending Class - GlobeNewswire
Morgan Stanley Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $23.00 - MarketBeat
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA - Newsfile
Dental Implants Market Size, Share, Growth Opportunities with CAGR of 7.1% by 2031 | DENTSPLY Sirona, - EIN News
Dentsply Sirona Hit By Class Action Lawsuit Over Byte Aligners Amid $495M Impairment, FDA Concerns - StockTitan
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Dentsply LawsuitXRAY - AccessWire
XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit - The Eastern Progress Online
Shareholders that lost money on Dentsply Sirona Inc. (XRAY) - GlobeNewswire
Shareholders that lost money on Dentsply Sirona Inc.(XRAY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Eastern Progress Online
Dentsply Sirona Hit With Class Action Lawsuit Over $495M Byte Aligner Business Impairment - StockTitan
Shareholders that lost money on Dentsply Sirona Inc.(XRAY) Urged - GuruFocus.com
XRAY LAWSUIT ALERT: Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AccessWire
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel - The Bakersfield Californian
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Dentsply - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before - EIN News
Kaplan Fox Alerts DENTSPLY SIRONA Investors to a Securities Class Action LawsuitDeadline is January 27, 2025 - The Globe and Mail
Levi & Korsinsky Reminds Dentsply Sirona Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025XRAY - The Malaysian Reserve
XRAYDENTSPLY SIRONA Inc. Latest Stock News & Market Updates - StockTitan
Lowey Dannenberg Notifies Dentsply Sirona Inc. (“Dentsply - GlobeNewswire
XRAY Stockholders Have Opportunity to Lead Dentsply Sirona Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend, Payable on January 10, 2025 - Marketscreener.com
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Issue Quarterly Dividend of $0.16 - MarketBeat
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
LUCIER GREGORY T | Director |
Nov 15 '24 |
Buy |
18.28 |
1,000 |
18,279 |
16,000 |
Campion Simon D | President, CEO & Member of BOD |
Nov 12 '24 |
Buy |
17.72 |
11,306 |
200,341 |
272,247 |
LUCIER GREGORY T | Director |
Aug 08 '24 |
Buy |
24.35 |
8,212 |
199,983 |
66,661 |
LUCIER GREGORY T | Director |
May 31 '24 |
Buy |
27.95 |
3,577 |
99,976 |
58,374 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):